Navigation Links
PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
Date:1/16/2012

SCHOFIELD, Wis., Jan. 16, 2012 /PRNewswire/ -- PuraMed BioScience, Inc. (OTCBB:PMBS) is pleased to announce the appointment of Sue A. Baacke, CPA, to the position of Chief Financial Officer.

Since 2009, Baacke has served as the Corporate Controller for PuraMed BioScience, Inc. gaining extensive experience in current SEC regulatory and compliance issues. Baacke came to PuraMed after holding a supervisory position at a well-established, Wisconsin-based, Certified Public Accounting firm for more than 12 years. Other experience includes auditing, preparation and review of financial statements, individual, corporate, and partnership income tax returns, payroll, and valuation of closely-held businesses.

Baacke's appointment allows PuraMed BioScience's former CFO / COO James Higgins to expand his role as chief operating officer.

"Our aim is to surpass the growth we have experienced during the last quarter through proficient management and development of our existing and new products as we continue to expand our national footprint and build our shareholder base," said Russ Mitchell, CEO of PuraMed BioScience. "We saw a need and an opportunity to strengthen our management team and we are pleased with this appointment."

Mitchell added, "Jim Higgins has done a stellar job for us as chief financial officer, and I look forward to his continued involvement as chief operating officer going forward."

About the PuraMed BioScience, Inc.:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products.  PuraMed has completed a double blind placebo clinical trial for its leading product, LipiGesic®M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. Please see the following link to view the abstract of that study. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract.

LipiGesic®M has national distribution and is available nationwide in some of the largest chain drug stores in the United States. In addition to LipiGesic M, PuraMed BioScience, Inc also has plans to launch LipiGesic®H for tension-type headaches as well as LipiGesic®PM which provides a remedy for insomnia and other sleep disorders.

Forward-Looking Statements: 
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

 

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

Investor Relations:
Investor Awareness, Inc.
Tony Schor or James Foy
847-945-2222
www.investorawareness.com

 

 

 

 


'/>"/>
SOURCE PuraMed BioScience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Seahorse Bioscience, Inc. Acquires BioProcessors Corp.
2. Seahorse Bioscience, Inc. Appoints In Vitro Technologies Pty Ltd as New Distributor in Australia and New Zealand
3. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
4. Omeros Appoints David A. Mann to its Board of Directors
5. RainDance Technologies Appoints Olex Vice President, System Development
6. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
7. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
8. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
9. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
10. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
11. UltraShape Appoints Assaf Eyal as President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... 30, 2016  GenomOncology today announced the appointment of ... Affairs.  Dr. Coleman will oversee clinical content ... knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with ... and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... , Nov. 30, 2016  The Allen ... Cell Collection: the first publicly available collection of ... cells that target key cellular structures with unprecedented ... Research, these powerful tools are a crucial first ... to better understand what makes human cells healthy ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... ... November 30, 2016 , ... Energetiq Technology, a world leader ... generation, ultra-bright, Laser-Driven Light Source, the EQ-77, at the MRS Fall Exhibit 2016. ... offers higher radiance and irradiance from a truly broadband white light source. The ...
Breaking Biology Technology:
(Date:11/17/2016)... it has just released a new white paper authored by Zettar that covers the ... transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a complicated endeavor ...
(Date:11/14/2016)... Calif. , Nov. 14, 2016 /PRNewswire/ ... biometric identification market, Frost & Sullivan recognizes ... & Sullivan Award for Visionary Innovation Leadership. ... in the biometric identification market by pioneering ... verification solution for instant, seamless, and non-invasive ...
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
Breaking Biology News(10 mins):